髋部骨折患者静脉血栓栓塞症的超额风险及合并症对预后的影响
基于丹麦全国健康登记数据的队列研究(1995-2015年)纳入110,563例髋部骨折患者和552,774例普通人群对照,发现髋部骨折后30天内静脉血栓栓塞症(VTE)调整风险比为17.29,31-365天为2.13,1年后风险比无显著升高;第一年内重度及极重度合并症与髋部骨折存在交互作用。
要点
- 髋部骨折患者30天内VTE调整HR为17.29(95%CI 14.74-20.28),31-365天为2.13(95%CI 1.95-2.32)。
- 1-5年及6-10年VTE相对风险分别为1.03(95%CI 0.96-1.11)和1.11(95%CI 1.00-1.23)。
- 30天内VTE后死亡率在髋部骨折队列为29.4%,普通人群队列为11.0%。
核心结论
- 髋部骨折患者在骨折后1年内VTE风险增加,第一年内重度及极重度合并症与髋部骨折存在交互作用。
研究设计与样本
- 基于丹麦健康登记数据的全国性队列研究,1995-2015年,纳入髋部骨折患者110,563例及普通人群对照552,774例。
- 采用Charlson合并症指数评估合并症,计算归因分数以评估髋部骨折与合并症交互作用对VTE率的贡献。
主要发现
- 髋部骨折患者VTE累积发生率30天内为0.73%、31-365天为0.83%,普通人群分别为0.05%和0.43%。
- 髋部骨折患者VTE调整HR在30天内为17.29(95%CI 14.74-20.28),31-365天为2.13(95%CI 1.95-2.32),1-5年为1.03(95%CI 0.96-1.11),6-10年为1.11(95%CI 1.00-1.23)。
- 30天内和31-365天,分别有14%和28%的VTE率归因于髋部骨折与重度合并症的交互作用,5%和4%归因于与极重度合并症的交互作用。
- VTE后30天内死亡率在髋部骨折队列为29.4%,普通人群队列为11.0%。
关键数值与推荐
- 髋部骨折患者VTE累积发生率在30天内为0.73%、31-365天为0.83%,普通人群对应为0.05%和0.43%。
- 髋部骨折患者VTE调整HR在30天内为17.29(95%CI 14.74-20.28),31-365天为2.13(95%CI 1.95-2.32),1-5年为1.03(95%CI 0.96-1.11),6-10年为1.11(95%CI 1.00-1.23)。
- 30天内和31-365天,归因于髋部骨折与重度合并症交互作用的VTE率比例分别为14%和28%,归因于与极重度合并症交互作用的比例分别为5%和4%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Hip fracture patients were at increased excess risk of venous thromboembolism (VTE) up to 1 year following hip fracture. During the first year, interaction between hip fracture and comorbidity was observed among patients with severe and very severe comorbidity. INTRODUCTION: We compared the risk of VTE in hip fracture patients with that in the general population. We also examined whether and to what extent the association between hip fracture and VTE varied by comorbidity level. METHODS: Nationwide cohort study based on Danish health registries, 1995-2015. We identified hip fracture patients (n = 110,563) and sampled a comparison cohort without hip fracture from the general population (n = 552,774). Comorbidity was assessed using the Charlson comorbidity index. We calculated attributable fraction, as the proportion of the VTE rate, among persons exposed to both hip fracture and comorbidity, attributed to exposure interaction. RESULTS: The cumulative incidences of VTE were 0.73% within 30 days and 0.83% within 31-365 days among hip fracture patients, and 0.05 and 0.43% in the general population. Adjusted hazard ratios (HRs) of VTE among hip fracture patients were 17.29 [95% confidence interval (CI) 14.74-20.28] during the first 30 days and 2.13 (95% CI 1.95-2.32) during 31-365 days following hip fracture. The relative risks of VTE were 1.03 (95% CI 0.96-1.11) and 1.11 (95% CI 1.00-1.23) after 1-5 years and 6-10 years. During the first 30 days and 31-365 days, 14%/28% of VTE rates and 5%/4% of VTE rates were attributable to the interaction between hip fracture and severe/very severe comorbidity, respectively. Mortality risks within 30 days of VTE were 29.4% in hip fracture and 11.0% in general population cohorts. CONCLUSIONS: Hip fracture patients were at increased excess risk of VTE up to 1 year following their fracture. During the first year, interaction between hip fracture and comorbidity was observed among patients with severe and very severe comorbidity.
引用
- Pedersen AB, Ehrenstein V, Szépligeti SK, et al. Excess risk of venous thromboembolism in hip fracture patients and the prognostic impact of comorbidity. Osteoporos Int. 2017. PMID: 28871320. doi:10.1007/s00198-017-4213-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。